Cancer Profiling Market by Technique (Genomics, Proteomics, Metabolomics, and Epigenetics), by Technology (Immunoassay, Hybridization, Next-Generation Sequencing, Mass Spectroscopy, and Others), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), and by Application (Personalized Cancer Medicine, Oncological Diagnostics, Research, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the cancer profiling market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the cancer profiling market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer profiling market on a global level.

In order to give the users of this report a comprehensive view of the cancer profiling market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the cancer profiling market on the basis of technique, technology, cancer type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of the global cancer profiling market are HTG Molecular Diagnostic, Illumina, NeoGenomics Laboratories, QIAGEN, Caris Life Sciences, Helomics Corporation, Oxford Gene Technology, Genomic Health, NanoString Technologies, and RiboMed Biotechnologies.

This report segments the global cancer profiling market as follows:

Global Cancer Profiling Market: Technique Analysis

	Genomics
	Proteomics
	Metabolomics
	Epigenetics

Global Cancer Profiling Market: Technology Analysis

	Immunoassay
	Hybridization
	Next-Generation Sequencing
	Mass Spectroscopy
	Others

Global Cancer Profiling Market: Cancer Type Analysis

	Breast Cancer
	Lung Cancer
	Colorectal Cancer
	Prostate Cancer
	Melanoma Cancer
	Others

Global Cancer Profiling Market: Application Analysis

	Personalized Cancer Medicine
	Oncological Diagnostics
	Research
	Others

Global Cancer Profiling Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa